This review concluded that mupirocin prophylaxis was effective in prevention of exit-site infection and peritonitis due to S. aureus and other organisms in patients who underwent peritoneal dialysis. This review was generally well conducted and the conclusions are likely to be reliable.
Authors' objectives
To determine whether mupirocin is effective for the prevention of exit-site infections and peritonitis in patients undergoing peritoneal dialysis.
Searching
MEDLINE, EMBASE, The Cochrane Library and Science Citation Index were searched for full-text studies published in English up to March 2009. Search terms were reported. Reference lists of retrieved articles were screened.
Study selection
Randomised controlled trials (RCT) and cohort studies that compared mupirocin to placebo or no treatment in adults (aged at least 18 years) who underwent peritoneal dialysis were eligible for inclusion. Studies needed to report data on the difference in rate of Staphylococcus aureus (S. aureus) infection (ESI or peritonitis) as the primary outcome measure.
Some studies only enrolled patients with S. aureus nasal colonisation. Mupirocin was administered as a cream or nasal ointment. There was variability between studies in the site, frequency and duration of administration.
The authors did not state how studies were selected for inclusion in the review.
Assessment of study quality
Two reviewers independently assessed study quality with the five-point Jadad scale of randomisation, blinding and handling of withdrawals. Disagreements were resolved through consensus.
Data extraction
Two reviewers independently extracted data on numbers of events and participants in the intervention and control groups and used these to calculate relative risks (RR) together with 95% confidence intervals (CIs). Disagreements were resolved through consensus.
Methods of synthesis
Summary relative risks were estimated using the fixed-effect model (in the absence of heterogeneity) or the DerSimonian and Laird random-effects model (in the presence of heterogeneity, p<0.05). Heterogeneity was assessed using the X 2 and I 2 statistics. Sensitivity analysis was conducted by restricting the analysis to recently published studies and to RCTs. Publication bias was assessed using funnel plots and the Begg test.
